{"id":49207,"date":"2022-10-05T19:02:01","date_gmt":"2022-10-05T17:02:01","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/outlook-on-the-cystic-fibrosis-global-market-to-2030-featuring-roche-nestle-health-science-abbvie-and-viatris-among-others-researchandmarkets-com\/"},"modified":"2022-10-05T19:02:01","modified_gmt":"2022-10-05T17:02:01","slug":"outlook-on-the-cystic-fibrosis-global-market-to-2030-featuring-roche-nestle-health-science-abbvie-and-viatris-among-others-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/outlook-on-the-cystic-fibrosis-global-market-to-2030-featuring-roche-nestle-health-science-abbvie-and-viatris-among-others-researchandmarkets-com\/","title":{"rendered":"Outlook on the Cystic Fibrosis Global Market to 2030 &#8211; Featuring Roche, Nestle Health Science, AbbVie and Viatris Among Others &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5653632\/cystic-fibrosis-market-share-size-trends-by?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=3pdl22&amp;utm_campaign=1758508+-+Outlook+on+the+Cystic+Fibrosis+Global+Market+to+2030+-+Featuring+Roche%2C+Nestle+Health+Science%2C+AbbVie+and+Viatris+Among+Others&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Cystic Fibrosis Market Share, Size, Trends By Drug Class, Route of Administration, By Distribution Channel, By Region, Segment Forecast, 2022 &#8211; 2030&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221005005666\/en\/1593102\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221005005666\/en\/1593102\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe global cystic fibrosis market is expected to reach USD 37.04 billion by 2030, rising at a CAGR of 24.3% over the forecast period.\n<\/p>\n<p>\n<strong>Companies Mentioned<\/strong>\n<\/p>\n<ul>\n<li>\nVertex Pharmaceutical Incorporated\n<\/li>\n<li>\nRoche\n<\/li>\n<li>\nNestle Health Science\n<\/li>\n<li>\nAbbVie\n<\/li>\n<li>\nViatris Inc.\n<\/li>\n<li>\nHorizon Therapeutic Plc.\n<\/li>\n<li>\nNovartis AG\n<\/li>\n<li>\nMylan N.V\n<\/li>\n<li>\nPfizer Inc\n<\/li>\n<li>\nBayerAG\n<\/li>\n<li>\nAstrazeneca\n<\/li>\n<li>\nGenentech Inc\n<\/li>\n<li>\nGilead Sciences\n<\/li>\n<li>\nChiesi Farmacrutici\n<\/li>\n<li>\nPharmaxis Ltd.\n<\/li>\n<li>\nTeva Pharmaceuticals\n<\/li>\n<\/ul>\n<p>\nThis report gives a detailed insight into current market dynamics and provides analysis on future market growth.\n<\/p>\n<p>\nRising awareness about cystic fibrosis and growing adoption of drug therapies are the prominent factors driving the cystic fibrosis market growth. A variety of oral and inhaled drugs are available for the treatment that increases compliance to the treatment owing to the ease and convenience of administering it. The widespread availability of different cystic fibrosis treatment options will expand the market size over the coming years.\n<\/p>\n<p>\nCystic fibrosis is a genetic disorder that affects more than 30,000 people in the U.S. and over 70,000 people are suffering from it worldwide. Additionally, more than approximately 1000 new cases of the disease are diagnosed every year.\n<\/p>\n<p>\nFavorable technological advancements in this therapeutic area will open new avenues of growth for industry participants. Rising innovation in the development of new therapies and drug products to cure cystic fibrosis is anticipated to foster growth in the cystic fibrosis market over the analysis period.\n<\/p>\n<p>\nRising number of cases of respiratory illness post Covid-19 pandemic has spurred the cystic fibrosis market growth. It has given the key industry players an opportunity to focus on the development of new drugs that can enable fast recovery and reduce mortality rates across the globe.\n<\/p>\n<p>\nHigh cost of treatment, stringent regulations prolong approval of drugs, and adverse effects of currently available drugs such as liver problems, upper respiratory tract infection, chest pain, and increased blood pressure among others will hinder the future market growth.\n<\/p>\n<p>\n<strong>Cystic Fibrosis Market Highlights<\/strong>\n<\/p>\n<ul>\n<li>\nCFTR modulators segment is anticipated to grow at a significant CAGR over the forecast period owing to their efficacy in improving body function at the cellular level and positively impact the quality of life.\n<\/li>\n<li>\nOral drugs accounted for a significant share owing to the preference among patients and medical practitioners due to the ease and convenience associated with administering the cystic fibrosis drugs.\n<\/li>\n<li>\nHospital segment is expected to hold a significant market share among the distribution channels over the forecast period owing to the rising need for precise diagnosis and required medical supervision associated with the treatment. Moreover, the rising number of patient hospital visits will fuel the hospital segment growth.\n<\/li>\n<li>\nNorth America is expected to grow at a significant CAGR over the projected period on account of the increasing incidence of cystic fibrosis and the availability of multiple treatment options in the region.\n<\/li>\n<li>\nGlobal players include Vertex Pharmaceutical, Genentech Inc., Teva Pharmaceuticals, Gilead Sciences, Roche, Nestle Health Science, AbbVie, Vitric Inc., Novartis AG, Mylan N.V, Pfizer Inc., Bayer, AstraZeneca, and Horizon Therapeutic, among others.\n<\/li>\n<\/ul>\n<p>\n<strong>The publisher has segmented the cystic fibrosis market report based on drug class, route of administration, distribution channel, and region:<\/strong>\n<\/p>\n<p>\n<strong>Cystic Fibrosis Market, By Drug Class (Revenue &#8211; USD Billion, 2018 &#8211; 2030)<\/strong>\n<\/p>\n<ul>\n<li>\nCFTR modulators\n<\/li>\n<li>\nMucolytics\n<\/li>\n<li>\nBronchodilators\n<\/li>\n<li>\nPancreatic enzyme supplements\n<\/li>\n<li>\nOthers\n<\/li>\n<\/ul>\n<p>\n<strong>Cystic Fibrosis Market, By Route of Administration (Revenue &#8211; USD Billion, 2018 &#8211; 2030)<\/strong>\n<\/p>\n<ul>\n<li>\nOral drugs\n<\/li>\n<li>\nParenteral drugs\n<\/li>\n<\/ul>\n<p>\n<strong>Cystic Fibrosis Market, By Distribution Channel (Revenue &#8211; USD Billion, 2018 &#8211; 2030)<\/strong>\n<\/p>\n<ul>\n<li>\nHospital\n<\/li>\n<li>\nRetail pharmacies\n<\/li>\n<li>\nOthers\n<\/li>\n<\/ul>\n<p>\n<strong>Cystic Fibrosis Market, By Region (Revenue &#8211; USD Billion, 2018 &#8211; 2030)<\/strong>\n<\/p>\n<ul>\n<li>\nNorth America\n<\/li>\n<li>\nU.S.\n<\/li>\n<li>\nCanada\n<\/li>\n<li>\nEurope\n<\/li>\n<li>\nGermany\n<\/li>\n<li>\nUK\n<\/li>\n<li>\nFrance\n<\/li>\n<li>\nItaly\n<\/li>\n<li>\nSpain\n<\/li>\n<li>\nRussia\n<\/li>\n<li>\nNetherlands\n<\/li>\n<li>\nAsia Pacific\n<\/li>\n<li>\nChina\n<\/li>\n<li>\nIndia\n<\/li>\n<li>\nJapan\n<\/li>\n<li>\nSouth Korea\n<\/li>\n<li>\nIndonesia\n<\/li>\n<li>\nMalaysia\n<\/li>\n<li>\nLatin America\n<\/li>\n<li>\nArgentina\n<\/li>\n<li>\nBrazil\n<\/li>\n<li>\nMexico\n<\/li>\n<li>\nMiddle East &amp; Africa\n<\/li>\n<li>\nUAE\n<\/li>\n<li>\nSaudi Arabia\n<\/li>\n<li>\nIsrael\n<\/li>\n<li>\nSouth Africa\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5653632\/cystic-fibrosis-market-share-size-trends-by?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=3pdl22&amp;utm_campaign=1758508+-+Outlook+on+the+Cystic+Fibrosis+Global+Market+to+2030+-+Featuring+Roche%2C+Nestle+Health+Science%2C+AbbVie+and+Viatris+Among+Others&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/t7ank4<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#x69;l&#116;&#x6f;:&#112;&#x72;&#x65;&#115;&#x73;&#x40;r&#101;&#x73;e&#97;&#x72;&#x63;&#104;&#x61;&#x6e;d&#109;&#x61;r&#107;&#x65;&#x74;&#115;&#x2e;&#x63;o&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#x70;&#114;&#101;s&#x73;&#x40;&#114;e&#x73;&#x65;&#97;rc&#x68;&#97;&#110;d&#x6d;&#x61;&#114;k&#x65;&#x74;&#115;&#46;c&#x6f;&#x6d;<\/a><\/p>\n<p>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Cystic Fibrosis Market Share, Size, Trends By Drug Class, Route of Administration, By Distribution Channel, By Region, Segment Forecast, 2022 &#8211; 2030&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global cystic fibrosis market is expected to reach USD 37.04 billion by 2030, rising at a CAGR of 24.3% over the forecast period. &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/outlook-on-the-cystic-fibrosis-global-market-to-2030-featuring-roche-nestle-health-science-abbvie-and-viatris-among-others-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49207","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Outlook on the Cystic Fibrosis Global Market to 2030 - Featuring Roche, Nestle Health Science, AbbVie and Viatris Among Others - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/outlook-on-the-cystic-fibrosis-global-market-to-2030-featuring-roche-nestle-health-science-abbvie-and-viatris-among-others-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Outlook on the Cystic Fibrosis Global Market to 2030 - Featuring Roche, Nestle Health Science, AbbVie and Viatris Among Others - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Cystic Fibrosis Market Share, Size, Trends By Drug Class, Route of Administration, By Distribution Channel, By Region, Segment Forecast, 2022 &#8211; 2030&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global cystic fibrosis market is expected to reach USD 37.04 billion by 2030, rising at a CAGR of 24.3% over the forecast period. ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/outlook-on-the-cystic-fibrosis-global-market-to-2030-featuring-roche-nestle-health-science-abbvie-and-viatris-among-others-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-05T17:02:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221005005666\/en\/1593102\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/outlook-on-the-cystic-fibrosis-global-market-to-2030-featuring-roche-nestle-health-science-abbvie-and-viatris-among-others-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/outlook-on-the-cystic-fibrosis-global-market-to-2030-featuring-roche-nestle-health-science-abbvie-and-viatris-among-others-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Outlook on the Cystic Fibrosis Global Market to 2030 &#8211; Featuring Roche, Nestle Health Science, AbbVie and Viatris Among Others &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-10-05T17:02:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/outlook-on-the-cystic-fibrosis-global-market-to-2030-featuring-roche-nestle-health-science-abbvie-and-viatris-among-others-researchandmarkets-com\\\/\"},\"wordCount\":709,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/outlook-on-the-cystic-fibrosis-global-market-to-2030-featuring-roche-nestle-health-science-abbvie-and-viatris-among-others-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221005005666\\\/en\\\/1593102\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/outlook-on-the-cystic-fibrosis-global-market-to-2030-featuring-roche-nestle-health-science-abbvie-and-viatris-among-others-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/outlook-on-the-cystic-fibrosis-global-market-to-2030-featuring-roche-nestle-health-science-abbvie-and-viatris-among-others-researchandmarkets-com\\\/\",\"name\":\"Outlook on the Cystic Fibrosis Global Market to 2030 - Featuring Roche, Nestle Health Science, AbbVie and Viatris Among Others - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/outlook-on-the-cystic-fibrosis-global-market-to-2030-featuring-roche-nestle-health-science-abbvie-and-viatris-among-others-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/outlook-on-the-cystic-fibrosis-global-market-to-2030-featuring-roche-nestle-health-science-abbvie-and-viatris-among-others-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221005005666\\\/en\\\/1593102\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-10-05T17:02:01+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/outlook-on-the-cystic-fibrosis-global-market-to-2030-featuring-roche-nestle-health-science-abbvie-and-viatris-among-others-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/outlook-on-the-cystic-fibrosis-global-market-to-2030-featuring-roche-nestle-health-science-abbvie-and-viatris-among-others-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/outlook-on-the-cystic-fibrosis-global-market-to-2030-featuring-roche-nestle-health-science-abbvie-and-viatris-among-others-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221005005666\\\/en\\\/1593102\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221005005666\\\/en\\\/1593102\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/outlook-on-the-cystic-fibrosis-global-market-to-2030-featuring-roche-nestle-health-science-abbvie-and-viatris-among-others-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Outlook on the Cystic Fibrosis Global Market to 2030 &#8211; Featuring Roche, Nestle Health Science, AbbVie and Viatris Among Others &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Outlook on the Cystic Fibrosis Global Market to 2030 - Featuring Roche, Nestle Health Science, AbbVie and Viatris Among Others - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/outlook-on-the-cystic-fibrosis-global-market-to-2030-featuring-roche-nestle-health-science-abbvie-and-viatris-among-others-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Outlook on the Cystic Fibrosis Global Market to 2030 - Featuring Roche, Nestle Health Science, AbbVie and Viatris Among Others - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Cystic Fibrosis Market Share, Size, Trends By Drug Class, Route of Administration, By Distribution Channel, By Region, Segment Forecast, 2022 &#8211; 2030&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global cystic fibrosis market is expected to reach USD 37.04 billion by 2030, rising at a CAGR of 24.3% over the forecast period. ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/outlook-on-the-cystic-fibrosis-global-market-to-2030-featuring-roche-nestle-health-science-abbvie-and-viatris-among-others-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-05T17:02:01+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221005005666\/en\/1593102\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/outlook-on-the-cystic-fibrosis-global-market-to-2030-featuring-roche-nestle-health-science-abbvie-and-viatris-among-others-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/outlook-on-the-cystic-fibrosis-global-market-to-2030-featuring-roche-nestle-health-science-abbvie-and-viatris-among-others-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Outlook on the Cystic Fibrosis Global Market to 2030 &#8211; Featuring Roche, Nestle Health Science, AbbVie and Viatris Among Others &#8211; ResearchAndMarkets.com","datePublished":"2022-10-05T17:02:01+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/outlook-on-the-cystic-fibrosis-global-market-to-2030-featuring-roche-nestle-health-science-abbvie-and-viatris-among-others-researchandmarkets-com\/"},"wordCount":709,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/outlook-on-the-cystic-fibrosis-global-market-to-2030-featuring-roche-nestle-health-science-abbvie-and-viatris-among-others-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221005005666\/en\/1593102\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/outlook-on-the-cystic-fibrosis-global-market-to-2030-featuring-roche-nestle-health-science-abbvie-and-viatris-among-others-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/outlook-on-the-cystic-fibrosis-global-market-to-2030-featuring-roche-nestle-health-science-abbvie-and-viatris-among-others-researchandmarkets-com\/","name":"Outlook on the Cystic Fibrosis Global Market to 2030 - Featuring Roche, Nestle Health Science, AbbVie and Viatris Among Others - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/outlook-on-the-cystic-fibrosis-global-market-to-2030-featuring-roche-nestle-health-science-abbvie-and-viatris-among-others-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/outlook-on-the-cystic-fibrosis-global-market-to-2030-featuring-roche-nestle-health-science-abbvie-and-viatris-among-others-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221005005666\/en\/1593102\/21\/logo.jpg","datePublished":"2022-10-05T17:02:01+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/outlook-on-the-cystic-fibrosis-global-market-to-2030-featuring-roche-nestle-health-science-abbvie-and-viatris-among-others-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/outlook-on-the-cystic-fibrosis-global-market-to-2030-featuring-roche-nestle-health-science-abbvie-and-viatris-among-others-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/outlook-on-the-cystic-fibrosis-global-market-to-2030-featuring-roche-nestle-health-science-abbvie-and-viatris-among-others-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221005005666\/en\/1593102\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221005005666\/en\/1593102\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/outlook-on-the-cystic-fibrosis-global-market-to-2030-featuring-roche-nestle-health-science-abbvie-and-viatris-among-others-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Outlook on the Cystic Fibrosis Global Market to 2030 &#8211; Featuring Roche, Nestle Health Science, AbbVie and Viatris Among Others &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49207","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49207"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49207\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49207"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49207"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49207"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}